Editor's Picks Analysis & Opinion

Pepsico is a classic low-beta defensive stock Shares have returned a total of 24% over the past 12 months The Wall Street consensus outlook is bullish, but with little expected upside over the next...

As the busy Q2 earnings season starts, many investors are looking for opportunities in exchange-traded funds (ETFs) to diversify their portfolios and take advantage of the market’s leading...

Higher inflation eroding fixed income that investors generate from their portfolios In such a high-cost environment, it makes sense to buy dividend stocks that raise their payouts faster than the rate...

On Friday, shares of Tesla (NASDAQ:TSLA) dropped 3% to close out the trading week. Yesterday, the electric vehicle maker's stock fell 4.83%. It was the fourth decline for TSLA over five sessions.Since...

It's been quite a while since Disney (NYSE:DIS) stock was a good investment.Over 1-, 3-, 5- and 10-year periods, shares of the entertainment giant have lagged the S&P 500 (though the decade-long...

Morgan Stanley reports Q1 earnings on Apr. 14 The 3-month total return is -18.5% The Wall Street consensus rating is bullish, with expected 12-month return of almost 30% The market-implied outlook is...

This post was written exclusively for Investing.com Gold made a marginal new high in March Gold corrected while NEM shares kept rising NEM sending a signal for gold Mining stocks are leveraged...

Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or derivatives. With a...